{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T08:07:49Z","timestamp":1781251669813,"version":"3.54.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T00:00:00Z","timestamp":1694390400000},"content-version":"vor","delay-in-days":6066,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpain.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pain"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.jpain.2006.09.011","type":"journal-article","created":{"date-parts":[[2006,12,5]],"date-time":"2006-12-05T07:11:14Z","timestamp":1165302674000},"page":"175-184","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":130,"title":["Efficacy and Safety of OPANA ER (Oxymorphone Extended Release) for Relief of Moderate to Severe Chronic Low Back Pain in Opioid-Experienced Patients: A 12-Week, Randomized, Double-blind, Placebo-controlled Study"],"prefix":"10.1016","volume":"8","author":[{"given":"Martin E.","family":"Hale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Ahdieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Rauck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpain.2006.09.011_bib1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1177\/0091270004271969","article-title":"Oxymorphone extended release does not affect CYP2C9 or CYP3A4 metabolic pathways","volume":"45","author":"Adams","year":"2005","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jpain.2006.09.011_bib2","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1592\/phco.24.5.468.33347","article-title":"Pharmacokinetics and dose-proportionality of oxymorphone extended release and its metabolites: results of a randomized crossover study","volume":"24","author":"Adams","year":"2004","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jpain.2006.09.011_bib3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2165\/00126839-200506020-00004","article-title":"Single- and multiple-dose pharmacokinetic and dose-proportionality study of oxymorphone immediate-release tablets","volume":"6","author":"Adams","year":"2005","journal-title":"Drugs R D"},{"key":"10.1016\/j.jpain.2006.09.011_bib4","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1177\/0091270004266487","article-title":"Efficacy of oxymorphone extended release in postsurgical pain: A randomized clinical trial in knee arthroplasty","volume":"44","author":"Ahdieh","year":"2004","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jpain.2006.09.011_bib5","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1097\/01.brs.0000186860.23078.a8","article-title":"Transdermal fentanyl versus sustained release oral morphine in strong-opioid naive patients with chronic low back pain","volume":"30","author":"Allan","year":"2005","journal-title":"Spine"},{"key":"10.1016\/j.jpain.2006.09.011_bib6","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0376-8716(99)00074-5","article-title":"Efficacy of daily and alternate-day dosing regimens with the combination buprenorphine-naloxone tablet","volume":"58","author":"Amass","year":"2000","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jpain.2006.09.011_bib7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jpainsymman.2003.11.006","article-title":"Efficacy and safety of extended-release, once-daily tramadol in chronic pain: A randomized 12-week clinical trial in osteoarthritis of the knee","volume":"28","author":"Babul","year":"2004","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpain.2006.09.011_bib8","series-title":"Pharmacotherapy: A Pathophysiologic Approach","first-page":"1188","article-title":"Pain management","author":"Baumann","year":"2002"},{"key":"10.1016\/j.jpain.2006.09.011_bib9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-3565(25)20047-7","article-title":"Buprenorphine: Dose-related blockade of opioid challenge effects in opioid dependent humans","volume":"247","author":"Bickel","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jpain.2006.09.011_bib10","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/clpt.1988.13","article-title":"A clinical trial of buprenorphine: Comparison with methadone in the detoxification of heroin addicts","volume":"43","author":"Bickel","year":"1988","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jpain.2006.09.011_bib11","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/1097-0142(19951001)76:7<1283::AID-CNCR2820760728>3.0.CO;2-0","article-title":"Opioid pharmacotherapy in the management of cancer pain: A survey of strategies used by pain physicians for the selection of analgesic drugs and routes of administration","volume":"76","author":"Cherny","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.jpain.2006.09.011_bib12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1526-4637.2003.03002.x","article-title":"Effectiveness and safety of new oxycodone\/acetaminophen formulations with reduced acetaminophen for the treatment of low back pain","volume":"4","author":"Gammaitoni","year":"2003","journal-title":"Pain Med"},{"key":"10.1016\/j.jpain.2006.09.011_bib13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jpain.2004.09.005","article-title":"Efficacy and safety of oxymorphone extended release in chronic low back pain: Results of a randomized, double-blind, placebo- and active-controlled phase III study","volume":"6","author":"Hale","year":"2005","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2006.09.011_bib14","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1097\/00007632-199812010-00014","article-title":"Opioid therapy for chronic noncancer back pain: A randomized prospective study","volume":"23","author":"Jamison","year":"1998","journal-title":"Spine"},{"key":"10.1016\/j.jpain.2006.09.011_bib15","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1090-3801(02)00143-X","article-title":"Recommendations for using opioids in chronic non-cancer pain","volume":"7","author":"Kalso","year":"2003","journal-title":"Eur J Pain"},{"key":"10.1016\/j.jpain.2006.09.011_bib16","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.pain.2004.09.019","article-title":"Opioids in chronic non-cancer pain: Systematic review of efficacy and safety","volume":"112","author":"Kalso","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2006.09.011_bib17","series-title":"Applied Therapeutics: The Clinical Use of Drugs","first-page":"28","article-title":"Psychoactive substance use disorders","author":"Koda-Kimble","year":"2001"},{"key":"10.1016\/j.jpain.2006.09.011_bib18","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0197-2456(97)00118-9","article-title":"Threats to the validity of clinical trials employing enrichment strategies for sample selection","volume":"19","author":"Leber","year":"1998","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.jpain.2006.09.011_bib19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cct.2005.10.005","article-title":"Enriched analgesic efficacy studies: An assessment by clinical trial simulation","volume":"27","author":"Lemmens","year":"2006","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.jpain.2006.09.011_bib20","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.pain.2005.12.026","article-title":"Chronic pain and genetic background interact and influence opioid analgesia, tolerance, and physical dependence","volume":"121","author":"Liang","year":"2006","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2006.09.011_bib21","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/00002508-200409000-00012","article-title":"Sustained-release oxycodone dosing survey of chronic pain patients","volume":"20","author":"Marcus","year":"2004","journal-title":"Clin J Pain"},{"key":"10.1016\/j.jpain.2006.09.011_bib22","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/01.ajp.0000146215.86038.38","article-title":"Treatment of persistent pain associated with osteoarthritis with controlled-release oxycodone tablets in a randomized controlled clinical trial","volume":"21","author":"Markenson","year":"2005","journal-title":"Clin J Pain"},{"key":"10.1016\/j.jpain.2006.09.011_bib23","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1526-4637.2005.00057.x","article-title":"Oxymorphone extended-release tablets relieve moderate to severe pain and improve physical function in osteoarthritis: Results of a randomized, double-blind, placebo- and active-controlled phase III trial","volume":"6","author":"Matsumoto","year":"2005","journal-title":"Pain Med"},{"key":"10.1016\/j.jpain.2006.09.011_bib24","series-title":"Pain: Clinical Manual","author":"McCaffery","year":"1999"},{"key":"10.1016\/j.jpain.2006.09.011_bib25","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/01.mjt.0000139442.65914.f9","article-title":"Safety, tolerability, and effectiveness of oxymorphone extended release for moderate to severe osteoarthritis pain: A one-year study","volume":"12","author":"McIlwain","year":"2005","journal-title":"Am J Ther"},{"key":"10.1016\/j.jpain.2006.09.011_bib26","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1021\/jm000381r","article-title":"Investigation of the selectivity of oxymorphone- and naltrexone-derived ligands via site-directed mutagenesis of opioid receptors: Exploring the \u201caddress\u201d recognition locus","volume":"44","author":"Metzger","year":"2001","journal-title":"J Med Chem"},{"key":"10.1016\/j.jpain.2006.09.011_bib27","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1213\/00000539-200004000-00029","article-title":"Opioid substitution to improve the effectiveness of chronic noncancer pain control: A chart review","volume":"90","author":"Quang-Cantagrel","year":"2000","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jpain.2006.09.011_bib28","first-page":"CD004847","article-title":"Opioid switching to improve pain relief and drug tolerability","author":"Quigley","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jpain.2006.09.011_bib29","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/sj.tpj.6500327","article-title":"Clinical response to morphine in cancer patients and genetic variation in candidate genes","volume":"5","author":"Ross","year":"2005","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.jpain.2006.09.011_bib30","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0885-3924(97)00183-8","article-title":"Transdermal fentanyl as treatment for chronic low back pain","volume":"14","author":"Simpson","year":"1997","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpain.2006.09.011_bib31","first-page":"57","article-title":"Effectiveness and safety of oral extended-release oxymorphone for the treatment of cancer pain: A pilot study","volume":"13","author":"Sloan","year":"2005","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jpain.2006.09.011_bib32","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/02791072.2003.10400007","article-title":"The Clinical Opiate Withdrawal Scale (COWS)","volume":"35","author":"Wesson","year":"2003","journal-title":"J Psychoactive Drugs"}],"container-title":["The Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152659000601090X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152659000601090X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:43:17Z","timestamp":1761507797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152659000601090X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S152659000601090X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpain.2006.09.011","relation":{},"ISSN":["1526-5900"],"issn-type":[{"value":"1526-5900","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Safety of OPANA ER (Oxymorphone Extended Release) for Relief of Moderate to Severe Chronic Low Back Pain in Opioid-Experienced Patients: A 12-Week, Randomized, Double-blind, Placebo-controlled Study","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pain","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpain.2006.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 American Pain Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}